financetom
Business
financetom
/
Business
/
Government unlikely to extend IBC suspension beyond March 25
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Government unlikely to extend IBC suspension beyond March 25
Mar 24, 2021 1:28 PM

CNBC-TV18 has learnt that the government is unlikely to extend the suspension of the Insolvency and Bankruptcy Code (IBC) beyond March 25.

The IBC was suspended to protect COVID related defaults in March last year, first for six months and then extended twice until March 25, 2021. CNBC-TV18's Ritu Singh shares all the developments.

Watch the video for more.

(Edited by : Jerome Anthony)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Perrigo Agrees to Sell Dermacosmetics Branded Business for up to $382 Million
Perrigo Agrees to Sell Dermacosmetics Branded Business for up to $382 Million
Jul 14, 2025
08:58 AM EDT, 07/14/2025 (MT Newswires) -- Perrigo ( PRGO ) said Monday it has agreed to sell its dermacosmetics branded business for up to 327 million euros ($382 million) to Kairos Bidco, a KKR (KKR) managed investment vehicle. The transaction is to consist of 300 million euros in upfront cash and up to an additional 27 million euros contingent...
Biodexa Pharmaceuticals Files Europe Clinical Trial Application for Potential Familial Adenomatous Polyposis Treatment
Biodexa Pharmaceuticals Files Europe Clinical Trial Application for Potential Familial Adenomatous Polyposis Treatment
Jul 14, 2025
08:56 AM EDT, 07/14/2025 (MT Newswires) -- Biodexa Pharmaceuticals ( BDRX ) said Monday it has filed a clinical trial application with the European Medicines Agency for trial of Serenta in patients with familial adenomatous polyposis. Familial adenomatous polyposis is a genetic disease that if untreated often leads to colorectal cancer. The application is required to obtain approval to begin...
Sector Update: Consumer
Sector Update: Consumer
Jul 14, 2025
08:57 AM EDT, 07/14/2025 (MT Newswires) -- Consumer stocks were leaning lower pre-bell Monday as the Consumer Staples Select Sector SPDR Fund (XLP) was down 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was marginally declining recently. Kenvue ( KVUE ) said its board has appointed director Kirk Perry as interim chief executive officer, starting immediately. Shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved